🔗 Permalink

Inventor profile of:

Patrick Legembre

City:

Rennes

Country:

France

Published Applications:

8

Last publication date:

2021-08-05

Top Assignees for applications by Patrick Legembre

The entities that hold a legal rights for patent applications filed by inventor Legembre Patrick:

Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
Ecole des Hautes Etudes en Sante Publique (EHESP) 2 Rennes, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 2 Paris, France
UNIVERSITE DE RENNES 1 2 Rennes, France
UNIVERSITE PAUL SABATIER TOULOUSE III 1 Toulouse, France
UNIVERSITE DE RENNES 1 1 RENNES CEDEX, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE 1 Toulouse, France
UNIVERSITE DE BORDEAUX 1 Bordeaux, France
UNIVERSITÉ DE BORDEAUX 1 Bordeaux, France
UNIVERSITE DE BORDEAUX 1 Bourdeaux, France
UNIVERSITE DE RENNES I 1 Rennes, France
INSTITUT BERGONIE 1 Bordeaux, France
UNIVERSITE DE RENNES 1 Rennes, France
CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX 1 Talence, France
Université des Antilles et de la Guyane 1 Pointe-à-Pitre, France
Universit des Antilles et de la Guiyane 1 Pointe-a-pitre, France
INSTITUTE BERGONIE 1 Bordeaux, France
UNIVERSITY OF NOTTINGHAM 1 Nottingham, France
UNIVERSITÉ DE RENNES 1 Rennes, France
ECOLE DES HAUTES ETUDES EN SANTÉ PUBLIQUE (EHESP) 1 Rennes, France
UNIVERSITÉ DES ANTILLES ET DE LA GUYANE 1 Pointe-â-Pitre, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
INSTITUT BERGONIÉ 1 Bordeaux, France
Centre National de la Recherche Scientifique (CNRS 1 Paris, France
University of Nottingham 1 Nottingham, United Kingdom
Université de Bourgogne 1 Dijon, France

Recent patent applications by Legembre Patrick

Patrick Legembre from Rennes, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-08-05

US20210238143A1

Chemistry; metallurgy

Compounds and pharmaceutical compositions for reducing CD95-mediated cell motility

#2 | 2019-11-21

US20190350907A1

Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING CD95- MEDIATED CELL MOTILITY

#3 | 2019-03-21

US20190085050A1

Chemistry; metallurgy

Polypeptides and uses thereof for reducing CD95-mediated cell motility

#4 | 2018-10-18

US20180298104A1

Chemistry; metallurgy

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH17 MEDIATED DISEASES

#5 | 2017-02-16

US20170044234A1

Chemistry; metallurgy

Polypeptides and uses thereof for reducing CD95-mediated cell motility

#6 | 2016-11-10

US20160327561A1

Methods and pharmaceutical compositions for preventing or reducing metastatic dissemination

#7 | 2016-08-25

US20160244424A1

Chemistry; metallurgy

PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof

#8 | 2015-12-31

US20150377888A1

Methods for Predicting and Preventing Metastasis in Triple Negative Breast Cancers

InventorID:

1401489 ⎘